Persones / Equip Humà

Jordi Antón López

Buscador de publicacions

Publicacions

  • Foeldvari I, Torok KS, Klotsche J, Anton-Lopez J, Reis PC, Del Gado F, Denton C, Hinrichs B, Li SC, Pain C, Pilkington C, Cutolo M, Kasapcopur O, Khanna D, Ruperto N, Smith V and Furst DE.

    Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.

    ARTHRITIS CARE & RESEARCH . 75(12): 2453-2462. Nº de cites: 1

    [doi:10.1002/acr.25171]

  • Ruperto N, Lovell DJ, Berman A, Anton-Lopez J, Viola DO, Lauwerys B, Rama ME, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Ally M, Rubio-Pérez N, Gervais E, Van Zyl R, Wong R, Askelson M, Martini A and Brunner HI.

    Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.

    JOURNAL OF RHEUMATOLOGY . 50(11): 1471-1480. Nº de cites: 1

    [doi:10.3899/jrheum.2022-1320]

  • Moran Alvarez, Patricia, Andreu-Suarez, Africa, Caballero-Mota, Liz, Gassiot S, Berrueco R, Calzada-Hernández J, Vazquez-Diaz, Monica, Boteanu, Alina, Messia, Virginia, Giovannelli, Luigi, De Benedetti, Fabrizio, Anton-Lopez J and Bracaglia, Claudia.

    Haematological and other manifestations in the presence of antiphospholipid antibodies in a multicentric paediatric cohort

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(11): 2331-2337. Nº de cites: 1

    [doi:10.55563/clinexprheumatol/3mzh06]

  • Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Anton-Lopez J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L and Hernández-Rodríguez J.

    Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(10): 2105-2114. Nº de cites: 1

    [doi:10.55563/clinexprheumatol/ukegcc]

  • Gerritsma AM, Sutera D, Cantarini L, Cattalini M, Lachmann HJ, Minden K, Jansson AF, Touitou I, Bustaffa M, Anton-Lopez J, Insalaco A, Moreno E, Sanchez-Manubens J, Ruperto N, Frenkel J and Gattorno M.

    TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(10): 1998-2007. Nº de cites: 1

    [doi:10.55563/clinexprheumatol/am4phc]

  • Klotsche, J, Torok, KS, Kasapcopur, O, Adrovic, A, Terreri, MT, Sakamoto, AP, Katsicas, M, Sztajnbok, F, Marrani, E, Sifuentes-Giraldo, A, Stanevicha, V, Anton-Lopez J, Feldmann, B, Kostik, M, Nemcova, D, Santos, MJ, Appenzeller, S, Avcin, T, Battagliotti, C, Berntson, L, Bica, B, Brunner, J, Eleftheriou, D, Harel, L, Horneff, G, Kallinich, T, Minden, K, Nielsen, S, Patwardhan, A, Helmus, N and Foeldvari, I.

    Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis

    Journal of Scleroderma and Related Disorders . 8(3): 183-191. Nº de cites: 1

    [doi:10.1177/23971983231164700]

  • Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Anton-Lopez J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI and Ruperto N.

    Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.

    Lancet . 402(10401): 555-570. Nº de cites: 20

    [doi:10.1016/S0140-6736(23)00921-2]

  • Block J, Rashkova C, Castanon I, Zoghi S, Platon J, Ardy RC, Fujiwara M, Chaves B, Schoppmeyer R, van der Made CI, Jimenez Heredia R, Harms FL, Alavi S, Alsina L, Sanchez Moreno P, Ávila Polo R, Cabrera-Pérez R, Kostel Bal S, Pfajfer L, Ransmayr B, Mautner AK, Kondo R, Tinnacher A, Caldera M, Schuster M, Domínguez Conde C, Platzer R, Salzer E, Boyer T, Brunner HG, Nooitgedagt-Frons JE, Iglesias-Jimenez E, Deyà-Martinez A, Camacho-Lovillo M, Menche J, Bock C, Huppa JB, Pickl WF, Distel M, Yoder JA, Traver D, Engelhardt KR, Linden T, Kager L, Hannich JT, Hoischen A, Hambleton S, Illsinger S, Da Costa L, Kutsche K, Chavoshzadeh Z, van Buul JD, Anton-Lopez J, Calzada-Hernández J, Neth O, Viaud J, Nishikimi A, Dupré L and Boztug K.

    Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency

    NEW ENGLAND JOURNAL OF MEDICINE . 389(6): 527-539. Nº de cites: 6

    [doi:10.1056/NEJMoa2210054]

  • Bethencourt-Baute JJ, Montero N, Zacarias A, Nieto JC, López-Corbeto M, Boteanu A, Medrano M, Díaz-Cordovés Rego G, Vargas-Lebron C, Machín-García S, Expósito L, Cacheda AP, Bernabeu P, Veroz-González R, Fernández O, Enriquez Merayo E, Torrente V, Fernández-Alba MD, Gamir ML, López-Robledillo JC, Anton-Lopez J, Otero L and Bustabad S.

    Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry.

    reumatologia clinica . 19(6): 328-333.

    [doi:10.1016/j.reumae.2023.01.003]

  • De Benedetti F, Grom AA, Brogan PA, Bracaglia C, Pardeo M, Marucci G, Eleftheriou D, Papadopoulou C, Schulert GS, Quartier P, Anton-Lopez J, Laveille C, Frederiksen R, Asnaghi V, Ballabio M, Jacqmin P and de Min C.

    Efficacy and safety of emapalumab in macrophage activation syndrome

    ANNALS OF THE RHEUMATIC DISEASES . 82(6): 857-865. Nº de cites: 48

    [doi:10.1136/ard-2022-223739]